IMR Press / RCM / Special Issues / 1635842014529

Novel Gene Discovery in Cardiomyopathy

Submission deadline: 01 September 2022
Special Issue Editor
  • John Lynn Jefferies, MD, MPH
    Division of Cardiovascular Diseases, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
    Interests: Advanced heart failure; cardiomyopathy; mechanical circulatory support and transplant; Heritable causes of vascular disease; novel drug therapies for advanced heart failure; novel gene discovery in cardiomyopathy; characterization and management of left ventricular noncompaction (LVNC); early diagnosis and management of chemotherapy
Special Issue Information

Dear Colleagues,


The past decade has seen a tremendous amount of literature describing genetic triggers of cardiovascular disease. Genetic underpinnings have been reported across the spectrum of cardiology including arrhythmias, coronary artery disease, vascular disease, dyslipidemia, and myocardial dysfunction. The Special Issue “Novel Gene Discovery in Cardiomyopathy” will collect high-quality original research papers and comprehensive reviews on recent advances in our understanding of the genetics that drive cardiomyopathy phenotypes. These findings have important implications as they help us to understand mechanisms and potential targets for therapy. Furthermore, the understanding of heritable disease facilitates the screening of appropriate at-risk family members. The topics of interest include, but are not limited to:
● Dilated cardiomyopathy
● Hypertrophic cardiomyopathy
● Restrictive cardiomyopathy
● Arrhythmogenic cardiomyopathy
● Non-compaction cardiomyopathy
● Cardiomyopathies associated with rare disorders or syndromic disease
Manuscripts submitted to the Special Issue will be subjected to stringent selection criteria to ensure the privileged position of accepted contributions. Those that fail to pass the selection will be considered for publication in RCM as regular contributions.


Prof. Dr. John Lynn Jefferies

Guest Editor

Cardiovascular genetics
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Back to top